Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is more common in Saudi men than women.

Females are more likely than males to experience long-COVID symptoms and heart issues.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Certain peptides, caffeine, taurine, and an iron complex may improve hair regrowth when used with minoxidil and finasteride for hair loss.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Hangeshashinto's natural products may help treat stomatitis by reducing inflammation and cytotoxicity.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

Over half of young people in Saudi Arabia experience early gray hair, linked to factors like smoking, stress, and family history.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

African Americans faced worse COVID-19 outcomes due to a mix of social, environmental, and biological factors.

Regenerative therapies show promise for hair regrowth, but more research and standardization are needed.

Targeting endolysosomes may help treat COVID-19.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Genetic differences affect how people respond to COVID-19.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Sunscreen technology is improving with new ingredients and methods to better protect skin from sun damage.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Poor sleep during the pandemic may increase stress and worsen hair loss conditions.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

El plasma rico en plaquetas puede ayudar en la regeneración celular y podría ser útil en tratamientos complementarios para enfermedades sin cura específica.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.